Interactions between glycopeptides and beta-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylococcus haemolyticus

Antimicrob Agents Chemother. 2006 Jul;50(7):2577-82. doi: 10.1128/AAC.00260-06.

Abstract

Four isogenic derivatives with stably increased glycopeptide MICs (all become resistant to teicoplanin) were obtained from four glycopeptide-susceptible clinical isolates of Staphylococcus haemolyticus. All strains were extensively analyzed and compared for a number of distinctive features. In particular, the results provided insights into the puzzling issue of antistaphylococcal interactions between glycopeptides and beta-lactams, especially the paradox of double zones around beta-lactam disks and the relationships between autolysis rate and type of interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / metabolism
  • Anti-Bacterial Agents / pharmacology*
  • Drug Interactions
  • Drug Resistance, Bacterial*
  • Glycopeptides / metabolism
  • Glycopeptides / pharmacology*
  • Humans
  • Microbial Sensitivity Tests / methods
  • Staphylococcus haemolyticus / drug effects*
  • Staphylococcus haemolyticus / genetics
  • Teicoplanin / pharmacology*
  • beta-Lactams / metabolism
  • beta-Lactams / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Glycopeptides
  • beta-Lactams
  • Teicoplanin